Shared on 07 Aug 25

Fair value Decreased 4.50%

Despite ongoing pricing normalization, mixed end-market trends, and management's cautiously optimistic FY25 outlook, analysts expect earnings to stabilize and financial performance to improve, resulting in an unchanged consensus price target of $66.60. Analyst Commentary Increased likelihood of earnings stabilization.

Read more

0 votesShare

Shared on 30 Apr 25

Fair value Decreased 7.72%

Read more

0 votesShare

Shared on 23 Apr 25

Fair value Increased 0.22%

AnalystConsensusTarget has increased revenue growth from -1.7% to -1.6%.

Read more

0 votesShare

Shared on 17 Apr 25

Fair value Decreased 2.68%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 09 Apr 25

Fair value Decreased 3.28%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 02 Apr 25

Fair value Decreased 1.65%

Read more

0 votesShare

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Read more

0 votesShare

Shared on 11 Mar 25

Fair value Increased 1.67%

AnalystConsensusTarget has decreased revenue growth from 0.5% to -1.6%, decreased profit margin from 6.1% to 3.9%, increased future PE multiple from 18.9x to 25.4x and increased discount rate from 7.9% to 8.8%.

Read more

0 votesShare